| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |